Fed Study of Zonisamide Capsules 100 mg and Zonegran® Capsules 100 mg
Status:
Completed
Trial end date:
2004-01-01
Target enrollment:
Participant gender:
Summary
The objective of this study was to investigate the bioequivalence of Mylan's zonisamide, 100
mg capsules to Elan's Zonegran® 100 mg capsules following a single, oral 100 mg (1 x 100 mg)
dose administered under fed conditions.